David M. DeMedio
Nessuna posizione attualmente
Profilo
Mr. David M.
DeMedio, CPA, is Chief Services Officer at USA Technologies, Inc.
Mr. DeMedio also served on the board at Gammacan International, Inc.
He received his undergraduate degree from the Shippensburg University of Pennsylvania.
Precedenti posizioni note di David M. DeMedio
| Società | Posizione | Fine |
|---|---|---|
| CANTALOUPE, INC. | Direttore Finanziario/CFO | 31/08/2015 |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Direttore/Membro del Consiglio | 17/09/2008 |
Formazione di David M. DeMedio
| Shippensburg University of Pennsylvania | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CANTALOUPE, INC. | Finance |
| Aziende private | 1 |
|---|---|
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
- Borsa valori
- Insiders
- David M. DeMedio
